New ALS drug candidate prosetin enters early human safety trials
Disease control
Ongoing
This early-stage study tests whether a new drug, prosetin, is safe for people with ALS (Lou Gehrig's disease) and healthy volunteers. Researchers will give increasing doses to small groups and watch for side effects. The goal is to find a safe dose for future studies, not to cure…
Phase: PHASE1 • Sponsor: ProJenX • Aim: Disease control
Last updated May 01, 2026 15:59 UTC